PlainPill

Sertraline

Also known as Zoloft

The short answer. Most people who report on Sertraline say it did not help (only 37% of 86 positive). It is most often used for mood: 65% of 54 reports say that improved. It is well studied — 318 meta-analyses on PubMed. The most common complaint is fatigue.

What users report
37%helped86 reports · medium confidence
31 helped29 mixed26 didn't help

From 136 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
318
meta-analyses
906
RCTs
6,376
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Sertraline does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 318 meta-analyses on PubMed ↗ · 906 randomized trials ↗

Lancet · 2018 · Meta-analysis / systematic review
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.

PubMed 29477251 ↗
Lancet · 2019 · Meta-analysis / systematic review
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis

Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.

PubMed 30712879 ↗
Mol Psychiatry · 2023 · Meta-analysis / systematic review
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.

PubMed 36253442 ↗
Lancet Psychiatry · 2020 · Meta-analysis / systematic review
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

Conclusion: Despite the scarcity of high-quality evidence, fluoxetine (alone or in combination with CBT) seems to be the best choice for the acute treatment of moderate-to-severe depressive disorder in children and adolescents. However, the effects of these interventions might vary between individuals, so patients, carers, and clinicians should carefully balance the risk-benefit profile of efficacy, acceptability, and suicide risk of all active interventions in young patients with depression on a case-by-case basis.

PubMed 32563306 ↗
Registered clinical trials

436 human trials on ClinicalTrials.gov test Sertraline — 279 completed, 36 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.…”

Full label on DailyMed (NIH) ↗

FDA recalls

5 recalls of products named for Sertraline. Most recent:

  • 2025-12-17 · Class II: Defective container - seal not adhering to bottles record ↗
  • 2024-01-03 · Class II: CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product. record ↗
  • 2015-04-29 · Class II: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were… record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

218,311 adverse-event reports mention Sertraline. Most often reported:

  • Nausea · 13,859
  • Drug ineffective · 13,619
  • Fatigue · 12,825
  • Headache · 11,104
  • Anxiety · 10,372
  • Diarrhoea · 10,340

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Sertraline B — a highly likely cause of liver injury (12–50 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 38 research projects with Sertraline in the title, $42,610,478 in total (1990–2023). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Sertraline ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

fatigue ×6numbness ×3brain fog ×3sexual dysfunction ×3withdrawal ×2libido change ×2weight gain ×2drowsiness ×2

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“The first 2 months were amazing. No thinking before every word. I just reacted, talked, did things. Pleasure. I could enjoy games, sunrises, weather. Anxiety gone. Woke up with energy no exhaustion.”
HelpedRead the discussion ↗
“Zoloft changed everything. It gave me what felt like superpowers: hard erections and the ability to last up to an hour.”
MixedRead the discussion ↗
“a low dose of zoloft (50mg) has done wonders for my anxiety and ruminating thoughts. I feel more emotionally balanced.”
HelpedRead the discussion ↗
“I'm meant to be on 75mg of zoloft but I only take 50mg because 75 causes migraines. ... the zoloft helped my panic disorder and ocd but if anything made my depression worse.”
MixedRead the discussion ↗
Read more Sertraline reviews →
Top discussions (5)

Sertraline compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate